Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Thérapies Ciblées
Extract
A multi-center, open label phase II trial of TKI258 in FGFR1 amplified and non-amplified metastatic or advanced HER2 negative breast cancer.
Scientific Abstract
en cours d'intégration;